BioCentury
ARTICLE | Financial News

Provalis issues earnings warning

May 23, 2002 7:00 AM UTC

Metabolic and infectious diseases company Provalis (LSE:PRO; PVLS) said that sales for the fourth quarter ending June 30 will be about 20% lower than the expected L11.8 million ($17.2 million). The co...